These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26258485)

  • 21. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection.
    Carotenuto P; Looij D; Keldermans L; de Wolf F; Goudsmit J
    AIDS; 1998 Sep; 12(13):1591-600. PubMed ID: 9764777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons learned from humoral responses of HIV patients.
    McCoy LE; McKnight Á
    Curr Opin HIV AIDS; 2017 May; 12(3):195-202. PubMed ID: 28422783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.
    Cornelissen M; Euler Z; van den Kerkhof TL; van Gils MJ; Boeser-Nunnink BD; Kootstra NA; Zorgdrager F; Schuitemaker H; Prins JM; Sanders RW; van der Kuyl AC
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1135-1142. PubMed ID: 26910384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status.
    Lucar O; Su B; Potard V; Samri A; Autran B; Moog C; Debré P; Vieillard V
    EBioMedicine; 2017 Aug; 22():122-132. PubMed ID: 28712768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.
    Rouers A; Klingler J; Su B; Samri A; Laumond G; Even S; Avettand-Fenoel V; Richetta C; Paul N; Boufassa F; Hocqueloux L; Mouquet H; Rouzioux C; Lambotte O; Autran B; Graff-Dubois S; Moog C; Moris A;
    EBioMedicine; 2017 Jul; 21():158-169. PubMed ID: 28615147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased frequencies of CD8
    Palmer CD; Romero-Tejeda M; Scully EP; Lockhart A; Seaman MS; Goldenthal A; Piechocka-Trocha A; Walker BD; Chibnik LB; Jost S; Porichis F
    J Int AIDS Soc; 2016; 19(1):21136. PubMed ID: 27938646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies.
    Polonis VR; De Souza MS; Chanbancherd P; Chantakulkij S; Jugsudee A; Loomis-Price LD; Vancott TC; Garner R; Markowitz LE; Brown AE; Birx DL
    AIDS Res Hum Retroviruses; 2001 Jan; 17(1):69-79. PubMed ID: 11177385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.
    Georgiev IS; Doria-Rose NA; Zhou T; Kwon YD; Staupe RP; Moquin S; Chuang GY; Louder MK; Schmidt SD; Altae-Tran HR; Bailer RT; McKee K; Nason M; O'Dell S; Ofek G; Pancera M; Srivatsan S; Shapiro L; Connors M; Migueles SA; Morris L; Nishimura Y; Martin MA; Mascola JR; Kwong PD
    Science; 2013 May; 340(6133):751-6. PubMed ID: 23661761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naïve HIV-1-infected children from northern India.
    Prakash SS; Andrabi R; Kumar R; Lodha R; Kabra SK; Vajpayee M; Luthra K
    Arch Virol; 2012 Sep; 157(9):1797-801. PubMed ID: 22674340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing.
    Carter CC; Wagner GA; Hightower GK; Caballero G; Phung P; Richman DD; Pond SL; Smith DM
    Virology; 2015 Jan; 474():34-40. PubMed ID: 25463602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
    Sun Z; Li J; Hu X; Shao Y; Zhang MY
    Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profile in long-term non progressor HIV infected patients: in search of potential resistance factors.
    Luque MC; Santos CC; Mairena EC; Wilkinson P; Boucher G; Segurado AC; Fonseca LA; Sabino E; Kalil JE; Cunha-Neto E
    Mol Immunol; 2014 Nov; 62(1):63-70. PubMed ID: 24967879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivity.
    Skrabal K; Saragosti S; Labernardière JL; Barin F; Clavel F; Mammano F
    J Virol; 2005 Sep; 79(18):11848-57. PubMed ID: 16140761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.
    Candotti D; Costagliola D; Joberty C; Bonduelle O; Rouzioux C; Autran B; Agut H
    J Med Virol; 1999 Jul; 58(3):256-63. PubMed ID: 10447421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables.
    Doria-Rose NA; Klein RM; Daniels MG; O'Dell S; Nason M; Lapedes A; Bhattacharya T; Migueles SA; Wyatt RT; Korber BT; Mascola JR; Connors M
    J Virol; 2010 Feb; 84(3):1631-6. PubMed ID: 19923174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains.
    Ramirez Valdez KP; Kuwata T; Maruta Y; Tanaka K; Alam M; Yoshimura K; Matsushita S
    Virology; 2015 Jan; 475():187-203. PubMed ID: 25486586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.
    Marcelino JM; Borrego P; Nilsson C; Família C; Barroso H; Maltez F; Doroana M; Antunes F; Quintas A; Taveira N
    AIDS; 2012 Nov; 26(18):2275-84. PubMed ID: 23151495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects.
    Cecilia D; Kleeberger C; Muñoz A; Giorgi JV; Zolla-Pazner S
    J Infect Dis; 1999 Jun; 179(6):1365-74. PubMed ID: 10228056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission.
    Lathey JL; Tsou J; Brinker K; Hsia K; Meyer WA; Spector SA
    J Infect Dis; 1999 Aug; 180(2):344-50. PubMed ID: 10395848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals.
    Ballana E; Ruiz-de Andres A; Mothe B; Ramirez de Arellano E; Aguilar F; Badia R; Grau E; Clotet B; del Val M; Brander C; Esté JA
    Immunobiology; 2012 Sep; 217(9):889-94. PubMed ID: 22333575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.